Ogen and Executive dysfunction - a phase IV clinical study of FDA data
Summary:
We study 3,073 people who take Ogen (estropipate) or have Executive dysfunction. No report of Executive dysfunction is found in people who take Ogen.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Ogen?
Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.
What is Executive Dysfunction?
Executive dysfunction is found to be associated with 54 drugs and 129 conditions by eHealthMe. Check the latest studies of Executive dysfunction.
No report is found.
Do you take Ogen and have Executive dysfunction?
- Check whether Executive dysfunction is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ogen:
- Ogen (2,553 reports)
Executive dysfunction treatments and more:
- Executive dysfunction (520 reports)
How severe was Executive dysfunction and when was it recovered:
Expand to all the drugs that have ingredients of estropipate:
Browse all side effects of Ogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Executive dysfunction:
Browse all the conditions that are associated with Executive dysfunction:
How the study uses the data?
The study uses data from the FDA. It is based on estropipate (the active ingredients of Ogen) and Ogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hyperammonaemia and drugs of ingredients of mirtazapine - a second ago
- Could Xolair cause Pneumonia? - 5 seconds ago
- Risperidone and Parkinson'S Disease for Men aged 60+ - 5 seconds ago
- Risperidone and Shaking Palsy for Men aged 60+ - 5 seconds ago
- Risperidone and Paralysis Agitans for Men aged 60+ - 6 seconds ago
- Risperidone and Parkinsonism for Men aged 60+ - 6 seconds ago
- Could Primidone cause Anticonvulsant Drug Level Increased? - 6 seconds ago
- Hypogammaglobulinaemia and drugs of ingredients of valsartan - 10 seconds ago
- Could Plaquenil cause Hypogammaglobulinaemia? - 12 seconds ago
- Drug interactions of Zyvox and Cymbalta - 12 seconds ago